COCP
Cocrystal Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.19
+4.39%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 109.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 21.96x
- Price / sales
- 69.46x
- Price / cash flow
- -2.82x
Enterprise value
- Enterprise value
- $22.1M
- EV / sales
- 66.96x
- EV / EBITDA
- -2.33x
- EV / EBIT
- -2.19x
- Market cap
- $22.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026